The European Medicines Agency wants to include a restriction to the indication for Veklury (remdesivir), Gilead Sciences’ COVID-19 treatment that was fast-tracked and approved conditionally in the EU a few months ago.
The agency has recommended changing the drug's indication to make it clearer in which COVID-19 patients requiring supplemental oxygen the...